Premium
A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene
Author(s) -
Hüffmeier Ulrike,
Zenker Martin,
Hoyer Juliane,
Fahsold Raimund,
Rauch Anita
Publication year - 2006
Publication title -
american journal of medical genetics part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.064
H-Index - 112
eISSN - 1552-4833
pISSN - 1552-4825
DOI - 10.1002/ajmg.a.31547
Subject(s) - ptpn11 , noonan syndrome , neurofibromatosis , neurofibromin 1 , haploinsufficiency , genetics , phenotype , mutation , biology , frameshift mutation , neurofibromatosis type i , allele , gene , kras
Signs of neurofibromatosis type 1 (NF1) and Noonan syndrome (NS), two distinct autosomal dominant disorders, occur together in patients reported as Watson syndrome (WS), neurofibromatosis‐Noonan syndrome (NFNS), partial LEOPARD syndrome, NS with features of NF1, and NF1 with Noonan‐like features. The molecular basis of these combined phenotypes was poorly understood and controversially discussed over several decades. Only recently, there is increasing evidence for WS and NFNS being allelic to NF1 in the majority of patients. In this study we describe seven novel patients from five unrelated families with variable phenotypes of the NF1‐NS spectrum which were systematically analyzed for mutations in the disease‐causing genes NF1 for NF1 and PTPN11 for NS. Heterozygous mutations or deletions of NF1 were identified in all patients, while no PTPN11 mutation was found. The NF1 mutation segregated with the phenotype in both familial cases. These results support the hypothesis that variable phenotypes of the NF1‐NS spectrum represent variants of NF1 in the majority of cases. Constitutive deregulation of the Ras pathway either through activating mutations of PTPN11 or through haploinsufficiency of neurofibromin, which acts as a Ras‐inactivating GTP‐ase, is probably the common pathogenetic mechanism explaining the phenotypic overlap of NS and NF1. © 2006 Wiley‐Liss, Inc.